ALGN - Align Technology, Inc.
| Previous Close | 372.310 |
| Open | 369.880 |
| Bid | 371.480 x 900 |
| Ask | 371.640 x 1300 |
| Day's Range | 365.000 - 373.410 |
| 52 Week Range | 155.550 - 375.330 |
| Volume | 422,099 |
| Avg. Volume | 996,688 |
| Market Cap | 29.785B |
| Beta | 1.85 |
| PE Ratio (TTM) | 118.01 |
| EPS (TTM) | 3.149 |
| Earnings Date | Jul 25, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 360.40 |
- Zacks•4 hours ago
Neogen (NEOG) Earnings and Revenues Beat Estimates in Q4
Neogen (NEOG) sticks to its four-pronged growth strategy for steady progress. Also, the company's accretive buyouts and its broader international base are a boon.
- Zacks•6 hours ago
Is Align Technology (ALGN) Stock Outpacing Its Medical Peers This Year?
Is (ALGN) Outperforming Other Medical Stocks This Year?
- Zacks•6 hours ago
Has Align Technology (ALGN) Outpaced Other Medical Stocks This Year?
Is (ALGN) Outperforming Other Medical Stocks This Year?
- Zacks•6 hours ago
Can Solid Global Prospects Drive Align's (ALGN) Q2 Earnings?
Align Technology (ALGN) poised to gain on continued strength in all geographies in Q2.
- Zacks•7 hours ago
S&P 500 at 5-Month High: 5 Stocks Up More Than 45%
Given that S&P 500 is at 5-month high, we have presented a bunch of stocks that have easily led the way on the index gaining more than 45% in the same time frame.
- Zacks•23 hours ago
Stock-Picking is a Cult
A plea to Millennials to learn the greatest, most fascinating game on the planet.
- Zacks•yesterday
Abbott (ABT) Q2 Earnings & Revenues Top Estimates, View Up
Abbott (ABT) posts another quarter of strong EPD and Medical Devices performance. Particularly, Abbott has been riding high on a healthy growth within its Diabetes Care business.
- Zacks•yesterday
A How-To Plan for Picking Stocks
Confused about how you should start investing in stocks? Kevin Cook and Tracey Ryniec give you their best stock picking tips and secrets.
- Zacks•2 days ago
Haemonetics Gains on Strong Plasma, Wider Global Footprint
Strong growth of Haemonetics' (HAE) plasma-derived biopharmaceuticals is attributable to solid end-market demand.
- Zacks•2 days ago
Can Overall Growth Drive Align Technology (ALGN) Q2 Earnings?
Align Technology (ALGN) likely to gain from strength in Invisalign space as well as Scanner and Service business in Q2.
- Zacks•6 days ago
QIAGEN Test-Menu Expansion on Track, Low HPV Sales a Woe
QIAGEN's (QGEN) HPV sales in the United States remain tepid. Weak APAC sales are due to bleak applied testing business.
- Zacks•6 days ago
Trump's APAC Focus Puts Spotlight on These 3 MedTech Stocks
Despite the trade war upheaval in Asia, some medical device companies stand strong in the APAC region.
- Zacks•6 days ago
Here's Why You Should Add Edwards Lifesciences (EW) Now
We are upbeat about Edwards Lifesciences' (EW) strong transcatheter valve sales in the domestic market as well as overseas.
- Zacks•7 days ago
Zacks.com highlights: Deckers Outdoor, WellCare Health Plans, Align Technology, Capstone Turbine and Twitter
Zacks.com highlights: Deckers Outdoor, WellCare Health Plans, Align Technology, Capstone Turbine and Twitter
- Zacks•7 days ago
Can Medical Devices Strength Drive Abbott (ABT) Q2 Earnings?
Abbott (ABT) poised to gain on continued growth in Medical Devices business in Q2.
- Zacks•8 days ago
5 Stocks to Enjoy Earnings Beat Before Q2 Release
These top-ranked stocks are likely to beat on the bottom line in their next releases.
- Zacks•9 days ago
Abaxis (ABAX) and Zoetis Merger Deal Crosses HRS Hurdle
With the adoption of Abaxis' (ABAX) point-of-care diagnostic instruments post acquisition, the combined entity's veterinary diagnostics category should grow faster than the animal health industry.
- Zacks•10 days ago
Medtronic (MDT) Rides on Innovation, Rising Costs a Woe
Medtronic (MDT) continues to meaningfully accelerate all its three fundamental growth strategies, namely therapy innovation, globalization and economic value.
- Zacks•13 days ago
Here's Why You Should Add Bio-Rad (BIO) to Your Portfolio
We are upbeat about Bio-Rad's (BIO) solid growth in geographies like North America, China and Asia Pacific.
- Investopedia•14 days ago
12 Stocks That Can Lead in a Rocky Second Half
Against an economic landscape marked by rising interest rates and growing trade tensions, Goldman Sachs Group Inc. ( GS) believes that companies with strong balance sheets are particularly well-suited to ride out the turbulence.
- ACCESSWIRE•14 days ago
Free Technical Research on Abbott Laboratories and Three More Medical Equipment Equities
On Tuesday, July 03, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged lower at the closing bell. Taking into consideration last Tuesday's market sentiment, WallStEquities.com assessed the following Medical Appliances & Equipment equities this morning: Viveve Medical Inc. (NASDAQ: VIVE), Abbott Laboratories (NYSE: ABT), ABIOMED Inc. (NASDAQ: ABMD), and Align Technology Inc. (NASDAQ: ALGN). On Tuesday, shares in Englewood, Colorado headquartered Viveve Medical Inc. recorded a trading volume of 213,805 shares.
- Motley Fool•15 days ago
These 3 Stocks Shot Up 100% in 2017 -- Are They Still Buys?
After a stellar year, here are two stocks to buy and one to avoid.
- Zacks•16 days ago
Insulet Banks on Omnipod's Growing Market Reach, Runs Risks
We are upbeat about the solid uptake of Insulet's (PODD) Omnipod System in the United States and other geographies.
- GlobeNewswire•17 days ago
Align Technology to Announce Second Quarter 2018 Results on July 25, 2018
SAN JOSE, Calif., July 02, 2018-- Align Technology, Inc. announced today that the Company will report second quarter 2018 financial results on Wednesday, July 25, 2018 after the close of market. Financial ...
